Abstract
Acneiform eruption, psoriasis, folliculitis, and maculopapular eruption have been described as adverse reactions to lithium therapy. In controlled studies, patients treated with lithium developed more cutaneous reactions, particularly acne and psoriasis, than patients receiving other psychotropics, with a prevalence in lithium-treated patients as high as 45%. Male patients taking lithium are more susceptible to developing cutaneous reactions than their female counterparts. Lithium tends to worsen or precipitate cutaneous conditions that are characterized by the pathological findings of neutrophilic infiltration. As lithium-related cutaneous adverse effects can be distressing to patients and may affect medication compliance, attention should be paid to skin problems in patients receiving lithium therapy. Management without cessation of lithium therapy is usually feasible except in some patients with psoriasis that is resistant to treatment. Paradoxically, therapeutic effects of topically applied lithium have been noted in seborrheic dermatitis and recurrent herpes infections.
Similar content being viewed by others
References
Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349–52
El-Mallakh RS. Acute lithium neurotoxicity. Psychiatr Dev 1986; 4 (4): 311–28
Callaway CL, Hendrie HC, Luby ED. Cutaneous conditions observed in patients during treatment with lithium. Am J Psychiatry 1968; 124 (8): 1124–5
Kusumi Y. A cutaneous side effect of lithium: report of two cases. Dis Nerv Syst 1971; 32 (12): 853–4
Carter TN. The relationship of lithium carbonate to psoriasis. Psychosomatics 1972; 13 (5): 325–7
Chan HH, Wing Y, Su R, et al. A control study of the cutaneous side effects of chronic lithium therapy. J Affect Disord 2000; 57 (1–3): 107–13
Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983; 143: 42–50
Heng MC. Cutaneous manifestations of lithium toxicity. Br J Dermatol 1982; 106 (1): 107–9
Mercke Y, Sheng H, Khan T, et al. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12 (1): 35–42
Mortimer PS, Dawber RP. Hair loss and lithium. Int J Dermatol 1984; 23 (9): 603–4
Rubin MB. Lithium-induced Darier’s disease. J Am Acad Dermatol 1995; 32 (4): 674–5
Posey RE. Lithium carbonate dermatitis. JAMA 1972; 221 (13): 1517
Kuhnley EJ, Granoff AL. Exfoliative dermatitis during lithium treatment. Am J Psychiatry 1979; 136 (10): 1340–1
Rifkin A, Kurtin SB, Quitkin F, et al. Lithium-induced folliculitis. Am J Psychiatry 1973; 130 (9): 1018–9
Gupta AK, Knowles SR, Gupta MA, et al. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995; 32 (2 Pt 2): 382–6
Reiffers J, Dick P. Cutaneous side-effects of treatment with lithium. Dermatologica 1977; 155 (3): 155–63
McWhirter JD, Hashimoto K, Fayne S, et al. Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol 1987; 123 (9): 1120–2
Shukla VR, Borison RL. Lithium and lupus like syndrome. JAMA 1982; 248 (8): 921–2
Fearfield LA, Bunker CB. Pityriasis versicolor associated with oral lithium therapy. Clin Exp Dermatol 1997; 22 (1): 57–9
Evans DL, Martin W. Lithium carbonate and psoriasis. Am J Psychiatry 1979; 136 (10): 1326–7
Skoven I, Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol 1979; 115 (10): 1185–7
Lowe NJ, Ridgway HB. Generalized pustular psoriasis precipitated by lithium carbonate. Arch Dermatol 1978; 114 (12): 1788–9
Christodoulou GN, Georgala S, Vareltzides A, et al. Lithium in seborrheic dermatitis. Psychiatr J Univ Ott 1983; 8 (1): 27–9
Vestergaard P, Amdisen A, Schou M. Clinically significant side effects of lithium treatment: a survey of 237 patients in long-term treatment. Acta Psychiatr Scand 1980; 62 (3): 193–200
DiGiovanna JJ, Aoyagi T, Taylor JR, et al. Inhibition of epidermal adenyl cyclase by lithium carbonate. J Invest Dermatol 1981; 76 (4): 259–63
Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312 (5992): 315–21
Voorhees JJ, Duell EA. Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade: a defective chalone mechanism? Arch Dermatol 1971; 104 (4): 352–8
Voorhees JJ, Marcelo CL, Duell EA. Cyclic AMP, cyclic GMP, and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J Invest Dermatol 1975; 65 (1): 179–90
Rothstein G, Clarkson DR, Larsen W, et al. Effect of lithium on neutrophil mass and production. N Engl J Med 1978; 298 (4): 178–80
Ockenfels HM, Wagner SN, Keim-Maas C, et al. Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch Dermatol Res 1996; 288 (4): 173–8
Bloomfield FJ, Young MM. Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis. Br J Dermatol 1983 Jul; 109 (1): 9–13
Deandrea D, Walker N, Mehlmauer M, et al. Dermatological reactions to lithium: a critical review of the literature. J Clin Psychopharmacol 1982; 2 (3): 199–204
Rudolph RI. Lithium-induced psoriasis of the fingernails. J Am Acad Dermatol 1992; 26 (1): 135–6
Remmer HI, Falk WE. Successful treatment of lithium-induced acne [letter]. J Clin Psychiatry 1986; 47 (1): 48
Malt U. Lithium carbonate and tetracycline interaction [letter]. BMJ 1978; 2 (6135): 502
Francis GJ, Silverman AR, Saleh O, et al. Follicular mycosis fungoides associated with lithium. J Am Acad Dermatol 2001; 44 (2): 308–9
Shukla S, Mukherjee S. Lichen simplex chronicus during lithium treatment. Am J Psychiatry 1984; 141 (7): 909–10
Hoxtell E, Dahl MV. Xerosis from lithium carbonate [letter]. Arch Dermatol 1975; 111 (8): 1073–4
Srebrnik A, Bar-Nathan EA, Ilie B, et al. Vaginal ulcerations due to lithium carbonate therapy. Cutis 1991; 48 (1): 65–6
Efalith Multicenter Trial Group. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1992; 26 (3 Pt 2): 452–7
Langtry JA, Rowland Payne CM, Staughton RC, et al. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis. Clin Exp Dermatol 1997; 22 (5): 216–9
Horrobin DF. Lithium, fatty acid and seborrheic dermatitis: a new mechanism of lithium action and a new treatment for seborrheic dermatitis. Lithium 1990; 1: 149–55
Skinner GR. Lithium ointment for genital herpes [letter]. Lancet 1983; II: 288
Acknowledgements
No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeung, C.K., Chan, H.H.L. Cutaneous Adverse Effects of Lithium. Am J Clin Dermatol 5, 3–8 (2004). https://doi.org/10.2165/00128071-200405010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200405010-00002